SearchDictionaryMobileLogin

Anti-HIV agents. Vicriviroc: is the risk of cancer increased?

Authors
JournalTreatmentUpdate (TreatmentUpdate) 2006 Aug-Sep Vol. 18 Issue 4 Pg. 5-6 ISSN: 1181-7186 Canada
PMID17209230 (Publication Type: Newspaper Article)
Chemical References
  • 1-((4,6-dimethyl-5-pyrimidinyl)carbonyl)-4-(4-(2-methoxy-4-(trifluoromethyl)phenyl)ethyl-3-methyl-1-piperazinyl)-4-methylpiperidine
  • Anti-HIV Agents
  • Piperazines
  • Pyrimidines
  • Receptors, CCR5
Topics
  • Anti-HIV Agents (adverse effects, therapeutic use)
  • Female
  • HIV Infections (drug therapy)
  • Hodgkin Disease (etiology)
  • Humans
  • Lymphoma, Non-Hodgkin (etiology)
  • Male
  • Middle Aged
  • Piperazines (adverse effects, therapeutic use)
  • Pyrimidines (adverse effects, therapeutic use)
  • Receptors, CCR5 (antagonists & inhibitors)
  • Skin Neoplasms (etiology)
  • Stomach Neoplasms (etiology)